Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

DKAM Donville Kent Asset Management 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (DKAM Donville Kent Asset Management)

Primary Source Intelligence • Q1 2024 Letter Analysis

DKAM Donville Kent Asset Management Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, DKAM Donville Kent Asset Management. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+45.33%

Digest Analysis

Quick Take

"Small caps have reached their cheapest level ever and are entering a 5-7 year bull market as rates peak. The fund holds high-quality Canadian names like Zedcor (premium security services) and VitalHub (healthcare software with Constellation-like characteristics)."

Executive Summary

Donville Kent Asset Management believes small cap stocks are entering a new 5-7 year bull market after reaching their cheapest levels ever during the fastest rate increase in history. The fund is positioned in high-quality Canadian small caps with strong competitive advantages. Zedcor provides premium security tower services with AI-powered monitoring that management believes is superior to competitors, trading at less than 6x 2025 cash earnings with Texas expansion progressing well. VitalHub is compared to Constellation Software from 14 years ago, with similar market cap, growth rates, and margins, expected to see significant margin expansion and acquisition activity in 2024. Nuvei was taken private at $46 CAD per share after the fund significantly added to the position at $18-22 in late 2023, with proceeds to be redeployed into the cheapest investments. The manager sees the end of October 2023 as the bottom for small caps and expects the current rebound to continue as market attention improves with peaked interest rates.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

78%

CautiousHigh

High Conviction (78%)

High conviction demonstrated through concentrated portfolio with three named positions receiving detailed analysis. Manager provides specific valuation metrics (6x 2025 earnings for Zedcor), sizing information (significantly added to Nuvei), and makes bold comparisons (VitalHub to Constellation Software). Strong declarative language about multi-year thesis with specific timeframes.

Growth Outlook

75%

BearishBullish

Bullish (75%)

Manager is strongly bullish on small caps specifically, stating they are 'firmly' in a new 5-7 year bull market with rates having peaked. Uses confident language about the opportunity set being the 'cheapest level we have ever seen' and expects multi-year outperformance.

Risk Appetite

60%

DefensiveAggressive

Balanced (60%)

Portfolio is positioned for the small cap bull market thesis with concentrated positions in named holdings. Manager significantly added to Nuvei position and plans to redeploy proceeds into cheapest investments, showing selective risk-taking but not maximum leverage deployment.

Capital Deployment

45%

De-riskingDeploying

Net Neutral (45%)

Moderate deployment activity with manager significantly adding to Nuvei position in late 2023 and planning to redeploy buyout proceeds into cheapest investments. However, no specific cash level changes mentioned and deployment appears selective rather than aggressive across the portfolio.

Forward Guidance

70%

CautiousExpansionary

Expansionary (70%)

Clear deployment bias with plans to use Nuvei proceeds to increase positions in cheapest investments like Zedcor. Manager is actively adding to positions and expects significant developments at largest investments in coming weeks, indicating continued deployment activity.

Language Signal

80%

BearishBullish

Bullish (80%)

Overwhelmingly bullish language dominates the letter with terms like 'bull market,' 'cheapest level ever,' 'significantly higher,' 'impressive,' 'head and shoulders above,' and 'excited for what's to come.' Very little bearish or cautionary language present.

Perceived Risk

25%

Low RiskElevated

Low Risk (25%)

Low risk perception with manager viewing the previous selloff as creating opportunity rather than ongoing threat. Only risk mentioned is historical context of rate increases causing indiscriminate selling, which is now viewed as past tense with rates having peaked.

Opportunity Density

85%

ScarceAbundant

Abundant (85%)

Very high opportunity density with manager describing small caps at 'cheapest level we have ever seen' and having multiple attractive investments to highlight. References upcoming developments at largest investments and couple of IPOs of interest, suggesting abundant opportunity set.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Multi-year investment horizon with manager describing a 5-7 year bull market thesis for small caps. Specific mentions of 12 & 24 month expectations for Zedcor and multi-year margin expansion for VitalHub indicate patient capital approach with 2-5 year value realization expectations.